Novocebrin | CAS#36702-84-8 | CNS Stimulator

MedKoo Cat#: 592577 | Name: Novocebrin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Novocebrin is a central nervous system activator.

Chemical Structure

Novocebrin

CAS#36702-84-8

Theoretical Analysis

MedKoo Cat#: 592577

Name: Novocebrin

CAS#: 36702-84-8

Chemical Formula: C20H22ClNOS2

Exact Mass: 391.0831

Molecular Weight: 391.97

Elemental Analysis: C, 61.28; H, 5.66; Cl, 9.04; N, 3.57; O, 4.08; S, 16.36

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Novocebrin; D 8955; D-8955; D8955

IUPAC/Chemical Name

alpha-(1-((3,3-Di-3-thienylallyl)amino)ethyl)benzyl alcohol hydrochloride

InChi Key

BRPBPTNOXZNOML-UHFFFAOYSA-N

InChi Code

InChI=1S/C20H21NOS2.ClH/c1-15(20(22)16-5-3-2-4-6-16)21-10-7-19(17-8-11-23-13-17)18-9-12-24-14-18;/h2-9,11-15,20-22H,10H2,1H3;1H

SMILES Code

CC(C(O)C1=CC=CC=C1)NC/C=C(C2=CSC=C2)/C3=CSC=C3.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 391.97 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Thiemer K, Stroman F, Szelenyi I, von Schlichtegroll A. [Pharmacological effect of tinofedrine on cerebral and peripheral hemodynamics in the dog (author's transl)]. Arzneimittelforschung. 1978;28(8):1343-54. German. PubMed PMID: 582400. 2: Obermeier K, Niebch G, Thiemer K, Vergin H. [Studies on the pharmacokinetics and metabolism of tinofedrine]. Arzneimittelforschung. 1978;28(8):1360-7. German. PubMed PMID: 582402. 3: Obermeier K, Thiemer K, von Schlichtegroll A. [The influence of tinofedrine on cerebral energy metabolism in normotensive, hypotensive and hypoxemic rats after carotis ligation (author's transl)]. Arzneimittelforschung. 1978;28(8):1354-60. German. PubMed PMID: 582401. 4: Engel J, von Schlichtegroll A, Sheldrick WS. Synthesis and absolute configuration of a tinofedrine-oxazolidine derivative. Arzneimittelforschung. 1982;32(5):475-7. PubMed PMID: 7201821. 5: Saus A, Posselt K. [Synthesis of radioactively labelled tinofedrine (author's transl)]. Arzneimittelforschung. 1980;30(6):917-8. German. PubMed PMID: 7191263. 6: Thiele K, Posselt K, Heese J, Engel J. [Spectroscopic characterisation of tinofedrine (author's transl)]. Arzneimittelforschung. 1980;30(7):1057-9. German. PubMed PMID: 7191286. 7: Lehmann R, Denes R, Nienhaus R, Steinbach T, Lusztig G, Sanatger RM. Alteration of chromatin in early experimental arteriosclerosis. Artery. 1980;8(3):288-93. PubMed PMID: 7213038. 8: Thiele K, Posselt K, Offermanns H, Thiemer K. [New cerebrally active basic dithienyl compounds (author's tranls)]. Arzneimittelforschung. 1980;30(5):747-51. German. PubMed PMID: 7190413. 9: Spehr W. [The effect of tinofedrine on the EEG]. Arzneimittelforschung. 1978;28(8):1312-3. German. PubMed PMID: 582394. 10: Kleemann A, Heese J, Engel J. [Synthesis of germinal 3,3-dithienyl compounds (author's transl)]. Arzneimittelforschung. 1981;31(8):1178-83. German. PubMed PMID: 7197525. 11: Stroman F, Thiemer K. [Investigations on the general effects of tinofedrine on heart and blood circulation (author's transl)]. Arzneimittelforschung. 1981;31(11):1892-902. German. PubMed PMID: 7198471. 12: Ott E, Lechner H. [The effect of tiofedrine on brain perfusion in patients with cerebrovascular insufficiency]. Z Gesamte Inn Med. 1981 Feb 15;36(4):124-6. German. PubMed PMID: 7222859. 13: Thjemer K, Obermeier K. [Effect of tinofedrine on oxygen, glucose and lactate metabolism in dogs and rats]. Arzneimittelforschung. 1981;31(4):693-700. German. PubMed PMID: 7195717. 14: Merory J, Du Boulay GH, Marshall J, Morris J, Russell RW, Symon L, Thomas DJ. Effect of tinofedrine (Homburg D8955) on cerebral blood flow in multi-infarct dementia. J Neurol Neurosurg Psychiatry. 1978 Oct;41(10):900-2. PubMed PMID: 731238; PubMed Central PMCID: PMC493190. 15: Thiele K, Posselt K, Offermanns H. [On the synthesis of the cerebrally active compound tinofedrine (author's transl)]. Arzneimittelforschung. 1978;28(11):2047-8. German. PubMed PMID: 582902. 16: Jakovlev V, Thiemer K, Habersang S, Achterrath-Tuckermann U, von Schlichtegroll A, Sofia RD. [General pharmacological studies on tinofedrine (author's transl)]. Arzneimittelforschung. 1978;28(8):1335-43. German. PubMed PMID: 582399. 17: Lechner H, Ott E. [The influence of tinofedrine on fibrinogen and platelet aggregation in patients with recent cerebral infarction (author's transl)]. Klin Wochenschr. 1978 Nov 15;56(22):1137-8. German. PubMed PMID: 713434.